BACKGROUND AND OBJECTIVES: In the United States, relatively little is known about clinical outcomes of chronic kidney disease (CKD) in vulnerable populations utilizing public health systems. The primary study objectives were to describe patient characteristics, incident ESRD, and mortality in adults with nondialysis-dependent CKD receiving care in the health care safety net. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Time to ESRD and time to death were examined among a cohort of 15,353 ambulatory adults with nondialysis-dependent CKD from the Community Health Network of San Francisco. RESULTS: The mean age of the CKD cohort was 59.0 +/- 13.8 years; 50% of the cohort was younger than 60 years and 26% was younger than 50 years. Most (72%) were members of nonwhite racial-ethnic groups, 73% were indigent (annual income <$15,000) and 18% were uninsured. In adjusted analyses, blacks [hazard ratio (95% confidence interval), 4.00 (2.99 to 5.35)], Hispanics [2.20 (1.46 to 3.30)], and Asians/Pacific Islanders [3.84 (2.73 to 5.40)] had higher risks of progression to ESRD than non-Hispanic whites. The higher risk of progression to ESRD among nonwhite compared with white persons with CKD was not explained by lower relative mortality. CONCLUSIONS: Adults with CKD stages 3 to 5 cared for within an urban public health system were relatively young and predominantly nonwhite-both factors associated with a higher risk of progression to ESRD. These findings call for targeted efforts to assess the burden and progression of CKD within other public and safety-net health systems in this country.
BACKGROUND AND OBJECTIVES: In the United States, relatively little is known about clinical outcomes of chronic kidney disease (CKD) in vulnerable populations utilizing public health systems. The primary study objectives were to describe patient characteristics, incident ESRD, and mortality in adults with nondialysis-dependent CKD receiving care in the health care safety net. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Time to ESRD and time to death were examined among a cohort of 15,353 ambulatory adults with nondialysis-dependent CKD from the Community Health Network of San Francisco. RESULTS: The mean age of the CKD cohort was 59.0 +/- 13.8 years; 50% of the cohort was younger than 60 years and 26% was younger than 50 years. Most (72%) were members of nonwhite racial-ethnic groups, 73% were indigent (annual income <$15,000) and 18% were uninsured. In adjusted analyses, blacks [hazard ratio (95% confidence interval), 4.00 (2.99 to 5.35)], Hispanics [2.20 (1.46 to 3.30)], and Asians/Pacific Islanders [3.84 (2.73 to 5.40)] had higher risks of progression to ESRD than non-Hispanic whites. The higher risk of progression to ESRD among nonwhite compared with white persons with CKD was not explained by lower relative mortality. CONCLUSIONS: Adults with CKD stages 3 to 5 cared for within an urban public health system were relatively young and predominantly nonwhite-both factors associated with a higher risk of progression to ESRD. These findings call for targeted efforts to assess the burden and progression of CKD within other public and safety-net health systems in this country.
Authors: Rudolph A Rodriguez; Saunak Sen; Kala Mehta; Sandra Moody-Ayers; Peter Bacchetti; Ann M O'Hare Journal: Ann Intern Med Date: 2007-04-03 Impact factor: 25.391
Authors: Yoshio N Hall; Chi-yuan Hsu; Carlos Iribarren; Jeanne Darbinian; Charles E McCulloch; Alan S Go Journal: Kidney Int Date: 2005-11 Impact factor: 10.612
Authors: J A Gazmararian; D W Baker; M V Williams; R M Parker; T L Scott; D C Green; S N Fehrenbach; J Ren; J P Koplan Journal: JAMA Date: 1999-02-10 Impact factor: 56.272
Authors: Elizabeth F O Kern; Miriam Maney; Donald R Miller; Chin-Lin Tseng; Anjali Tiwari; Mangala Rajan; David Aron; Leonard Pogach Journal: Health Serv Res Date: 2006-04 Impact factor: 3.402
Authors: V Menon; X Wang; M J Sarnak; L H Hunsicker; M Madero; G J Beck; A J Collins; J W Kusek; A S Levey; T Greene Journal: Kidney Int Date: 2008-03-12 Impact factor: 10.612
Authors: Manjula Kurella-Tamura; Benjamin A Goldstein; Yoshio N Hall; Aya A Mitani; Wolfgang C Winkelmayer Journal: J Am Soc Nephrol Date: 2014-03-20 Impact factor: 10.121
Authors: Marlena Maziarz; R Anthony Black; Christine T Fong; Jonathan Himmelfarb; Glenn M Chertow; Yoshio N Hall Journal: J Am Soc Nephrol Date: 2014-12-04 Impact factor: 10.121
Authors: Michael J Fischer; Jesse Y Hsu; Claudia M Lora; Ana C Ricardo; Amanda H Anderson; Lydia Bazzano; Magdalena M Cuevas; Chi-Yuan Hsu; John W Kusek; Amada Renteria; Akinlolu O Ojo; Dominic S Raj; Sylvia E Rosas; Qiang Pan; Kristine Yaffe; Alan S Go; James P Lash Journal: J Am Soc Nephrol Date: 2016-05-05 Impact factor: 10.121
Authors: Laura C Plantinga; Min Kim; Margarethe Goetz; David G Kleinbaum; William McClellan; Rachel E Patzer Journal: Am J Nephrol Date: 2014-01-15 Impact factor: 3.754
Authors: James P Lash; Ana C Ricardo; Jason Roy; Rajat Deo; Michael Fischer; John Flack; Jiang He; Martin Keane; Claudia Lora; Akinlolu Ojo; Mahboob Rahman; Susan Steigerwalt; Kaixiang Tao; Myles Wolf; Jackson T Wright; Alan S Go Journal: Am J Kidney Dis Date: 2016-05-19 Impact factor: 8.860
Authors: Ann M O'Hare; John R Hotchkiss; Manjula Kurella Tamura; Eric B Larson; Brenda R Hemmelgarn; Adam Batten; Thy P Do; Kenneth E Covinsky Journal: JAMA Intern Med Date: 2014-03 Impact factor: 21.873